Vir Biotechnology advances VIR-5500 into expansion trials in prostate cancer

AKM and Kyoto University break ground with 2 µm PCSEL laser

Paves the way for next-gen ultra-precise gas sensing

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat

Scientists at the forum warned of an increasingly volatile health landscape

CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi

Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews

Aster DM Healthcare invests Rs 96 crore to add 159-bed specialised Aster Women & Children centre in Bengaluru

With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds

AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial

Highlights Mirvetuximab-based regimen promise

Pharma firms accelerate regional GLP-1 capacity to de-risk supply chains amid geopolitical tensions: GlobalData

At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy

Apollo Hospitals sets world record in robotic heart surgery with 100 procedures in 155 days

These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss

Glycomine completes enrollment in Phase 2b trial for rare genetic disorder

The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation

Chiba University study flags allergy risk in high-binding antibody drugs

For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms